肾功能与不明原因栓塞性卒中患者的风险分层
该研究汇总欧美12个ESUS数据集,共1530例患者随访3260患者年,发现缺血性卒中/TIA复发237例(15.9%)、死亡201例(13.4%)。肾功能无论连续、二分类或分类分析,均与缺血性卒中/TIA复发或死亡风险无关。
要点
- 在ESUS患者中,肾功能未显示可独立分层缺血性卒中/TIA复发风险。
- 肾功能与死亡结局的关联同样无统计学意义。
- 不同eGFR分期下卒中复发概率数值有差异,但整体检验无显著性。
核心结论
- 本研究未提供证据支持肾功能可用于ESUS患者缺血性卒中/TIA复发或死亡的风险分层。
研究设计与样本
- 汇总欧洲和美洲12个ESUS数据集,共1530例患者,随访3260患者年。
- 肾功能用eGFR评估,分别以连续、二分类和分类变量纳入Cox回归分析。
主要发现
- 随访期间发生237例缺血性卒中/TIA复发(15.9%)和201例死亡(13.4%),对应每100患者年7.3例复发和5.6例死亡。
- 肾功能作为连续变量时,每1 mL/min的HR为1.00(95%CI 0.99-1.00)。
- 肾功能作为二分类变量时,HR为1.27(95%CI 0.87-1.73)。
- 肾功能作为分类变量时,卒中复发的似然比检验为2.59,P=0.63。
- 不同eGFR分层的卒中复发概率:≥90为11.9%,60-89为16.6%,45-59为21.7%,30-44为19.2%,<30为24.9%。
临床怎么用
- 在ESUS患者风险分层中,不应仅依据肾功能来预测卒中复发或死亡风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- We aimed to assess if renal function can aid in risk stratification for ischemic stroke or transient ischemic attack (TIA) recurrence and death in patients with embolic stroke of undetermined source (ESUS). Methods- We pooled 12 ESUS datasets from Europe and America. Renal function was evaluated using the estimated glomerular filtration rate (eGFR) and analyzed in continuous, binary, and categorical way. Cox-regression analyses assessed if renal function was independently associated with the risk for ischemic stroke/TIA recurrence and death. The Kaplan-Meier product limit method estimated the cumulative probability of ischemic stroke/TIA recurrence and death. Results- In 1530 patients with ESUS followed for 3260 patient-years, there were 237 recurrences (15.9%) and 201 deaths (13.4%), corresponding to 7.3 ischemic stroke/TIA recurrences and 5.6 deaths per 100 patient-years, respectively. Renal function was not associated with the risk for ischemic stroke/TIA recurrence when forced into the final multivariate model, regardless if it was analyzed as continuous (hazard ratio, 1.00; 95% CI, 0.99-1.00 for every 1 mL/min), binary (hazard ratio, 1.27; 95% CI, 0.87-1.73) or categorical covariate (likelihood-ratio test 2.59, P=0.63 for stroke recurrence). The probability of ischemic stroke/TIA recurrence across stages of renal function was 11.9% for eGFR ≥90, 16.6% for eGFR 60-89, 21.7% for eGFR 45-59, 19.2% for eGFR 30-44, and 24.9% for eGFR <30 (likelihood-ratio test 2.59, P=0.63). The results were similar for the outcome of death. Conclusions- The present study is the largest pooled individual patient-level ESUS dataset, and does not provide evidence that renal function can be used to stratify the risk of ischemic stroke/TIA recurrence or death in patients with ESUS.
引用
- Ntaios G, Lip GYH, Lambrou D, et al. Renal Function and Risk Stratification of Patients With Embolic Stroke of Undetermined Source. Stroke. 2018. PMID: 30571398. doi:10.1161/STROKEAHA.118.023281
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。